Tandem Diabetes Care (TNDM) is a great long-term investment
What’s up with Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) opened at $74.62, which means the stock is up 8.11% from yesterday’s closing price of 74.57. Today, the company has a high of $80.38 and a low of $73.57. The company has a market cap of $4.79 billion with a 52-week high of $91.65 and a 52-week low of $43.69.
What about the future for Tandem Diabetes Care
The high forecast for Tandem Diabetes Care is 102.00 while the low is 65.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Tandem Diabetes Care has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information TNDM seems to be a safe buy.
About Tandem Diabetes Care
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.